Daniel Portsmouth

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger et al. · The Lancet Infectious Diseases · 2013 · 104 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

Annett Hessel, Helga Savidis-Dacho, Sogué Coulibaly et al. · PLoS ONE · 2014 · 63 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Nina Wressnigg, Perry Barrett, Eva-Maria Pöllabauer et al. · Clinical and Vaccine Immunology · 2014 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

An Inactivated Ross River Virus Vaccine Is Well Tolerated and Immunogenic in an Adult Population in a Randomized Phase 3 Trial

Nina Wressnigg, Maikel V. W. van der Velden, Daniel Portsmouth et al. · Clinical and Vaccine Immunology · 2014 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Developing cell culture-derived pandemic vaccines.

Perry Barrett, Daniel Portsmouth, Hartmut J. Ehrlich · PubMed · 2010 · 39 citations

Life Sciences, Biotechnology, Immunology +17